The Prevalence of Hyperglycemia in Surgical Patients With Pre-diabetes
1 other identifier
observational
750
1 country
1
Brief Summary
The goal of this study is to measure the prevalence and risks of hyperglycemia in surgical patients with prediabetes. The main questions it aims to answer are:
- What is the prevalence of hyperglycemia in surgical patients with prediabetes?
- What is the relative risk of postoperative complications associated with hyperglycemia? To answer these questions, surgical patients with prediabetes will undergo universal glucose measurement in the perioperative period. Glucose data will be analyzed in conjunction with electronic health record (EHR) data describing patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2027
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 23, 2026
CompletedStudy Start
First participant enrolled
May 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
Study Completion
Last participant's last visit for all outcomes
May 1, 2028
June 23, 2026
February 1, 2026
1 year
February 23, 2026
June 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of perioperative hyperglycemia
Prediabetes will be defined as described in Section 4.2 using Diabetes Canada definitions. The perioperative period will include the day of surgery and the early postoperative period. The day of surgery includes surgical admitting, intraoperative, and recovery room on postoperative day (POD) 0, which is the day that surgery was completed until 23:59. The early postoperative period will be defined as the first 3 full postoperative days, in keeping with studies that have demonstrated that hyperglycemia is most common in the first 72 hours after surgery and that early hyperglycemia is associated with greater 30-day postoperative mortality. Hyperglycemia will be defined using Diabetes Canada reference ranges as any glucose value \>10.0 mmol/L by any form of glucose measurement.
Up to the first 3 postoperative days or discharge, whichever comes first.
Secondary Outcomes (1)
Post-operative complications
Within 30 days of surgery.
Study Arms (1)
Surgical Patients with Prediabetes
Adult patients undergoing non-cardiac surgeries who have pre-diabetes.
Eligibility Criteria
Surgical in-patients at the Foothills Medical Centre.
You may qualify if:
- Hemoglobin A1c measurement between 6 and 6.4%
- Scheduled for non-cardiac surgery
You may not qualify if:
- Age\>18
- Pregnancy
- Any formal diabetes diagnosis
- Current use of medications that influence blood glucose regardless of the indication
- Undergoing cardiac, intracranial neurosurgery, bariatric, or pancreatic surgeries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foothills Medical Centre
Calgary, Alberta, Canada
Related Publications (1)
Ruzycki SM, Harrison TG, Lithgow KC, Cameron A, Philp L, Heatlie L, Esmail R, Ejaredar M, Helmle K, McKeen J, Dillane D. Day-of-surgery quality gaps in glycemic management: a retrospective cohort study. Perioper Med (Lond). 2025 Nov 25;14(1):143. doi: 10.1186/s13741-025-00628-3.
PMID: 41291884BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon Ruzycki, MD
University of Calgary
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 23, 2026
First Posted
June 23, 2026
Study Start (Estimated)
May 1, 2027
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
June 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available after analyses have completed, approximately in the month of March, 2028. Data will be retained in accordance with the University of Calgary's Master Records Retention Schedule(MaRRS). During this time period, data will be available upon reasonable request.
IPD, specifically deidentified patient data will be shared upon reasonable request by fellow research teams.